The characteristics and clinical course of patients with melioidosis and cancer
Patients with cancer are predisposed to developing melioidosis and immune suppressing anti-cancer therapy increases this risk further. However, in this region of Australia, there was no significant difference in the subsequent development of melioidosis in patients who did-and did not-receive TMP-SMX chemoprophylaxis during their myelosuppressive anti-cancer therapy.
Authors
- Tripti Shukla (ORCID: https://orcid.org/0000-0001-8250-2431)
- Josh Hanson (ORCID: https://orcid.org/0000-0002-1423-3839)
- Simon Smith (ORCID: https://orcid.org/0000-0002-7770-3738)
- Kieran Johnstone
- Peter R. Donald
Institutions
- Cairns Hospital (AU)
- UNSW Sydney (AU)
Publication Details
- Journal
- PLoS neglected tropical diseases
- Published
- 2024-10-25
- DOI
- https://doi.org/10.1371/journal.pntd.0012631
- Citations
- 4
- Primary Topic
- Burkholderia infections and melioidosis
- Type
- article
- Field-Weighted Citation Impact
- 1.55